Literature DB >> 420037

Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.

S Lal, N P Nair, P Cervantes, J Pulman, H Guyda.   

Abstract

Naloxone HCl (0.8 mg intravenously; n=9) or levallorphan tartrate (0.25 mg subcutaneously; n=5) had no effect on basal prolactin or growth hormone secretion in normal men. Neither narcotic antagonist inhibited the growth hormone secretory response to apomorphine HCl (0.75 mg subcutaneously). These findings suggest that narcotic antagonists do not block dopamine receptors in the hypothalamic-pituitary axis in man and that if these agents have antischizophrenic properties then these are not mediated by dopamine receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420037     DOI: 10.1111/j.1600-0447.1979.tb06959.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

2.  Failure of naloxone to antagonize metoclopramide induced prolactin rise.

Authors:  L Laurian; Z Oberman; D Ayalon; E Graf; A Fitermann; E Hoerer
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

3.  Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.

Authors:  D Naber; D Pickar; G C Davis; R M Cohen; D C Jimerson; M A Elchisak; E G Defraites; N H Kalin; S C Risch; M S Buchsbaum
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.